Insider buying last 90 days
No open-market insider purchases were filed for AIP in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Arteris reported record Q2 2026 results this week, with annual contract value plus royalties reaching $99.5 million, a 44% year-over-year increase, and revenue hitting $24.1 million, up 46%. Separately, the company announced an expansion of its third-party IP security assurance program with BAE Systems and SiFive, backed by $3.3 million in government funding through the Trusted and Assured Microelectronics program. A Form 4 filing also showed General Counsel Paul L. Alpern selling 6,003 shares on 5 October at a weighted average price of $24.2379.
The stock closed at $21.46, down 4.4% on the day, and sits below both its 50-day average of $24.29 and its 200-day average of $24.81, with the 50-day itself below the 200-day. Over three months the shares are down 35.8%, though they remain up 63.7% over the past year. The GekkoIndex reads 65.2, placing the stock in the Accumulation zone, and the current price sits 28.9% below the Gekko Fair Value of $30.19.
Arteris next reports earnings on 3 November 2026, after the close, which falls within the next 20 trading days; its last report showed a loss of $0.24 per share against a $0.16 estimate and a 3.7% reaction, with 6 beats in the last 8 quarters. No insider, Congress, or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged a 7.3% gain over 4 years, rising in 3 of them. All 7 covering analysts currently rate the stock buy, with a consensus target of $39.43.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Arteris scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
Below 50 and 200-day
Close $21.46 is below the 50-day ($24.29) and 200-day ($24.81) averages, and the 50-day is below the 200-day.
See the chart65.2, Accumulation
Reading 65.2 is in the Accumulation zone.
See the GekkoIndex28.9% below
Price is 28.9% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 22 days
Reports on Nov 3, 2026, 22 days away — inside a typical 20-trading-day hold.
See earnings+7.3% on average
From this point in the calendar, the next 20 trading days averaged +7.3% over 4 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Arteris closed at $21.46 on Oct 12, 2026, +63.7% over the past year, inside a 52-week range of $12.06 to $50.26.
Use the left and right arrow keys to read daily values.
Put AIP on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Arteris’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65.2, in the Accumulation zone, up 8.7 points over five sessions.
Up 8.7 points over five sessions, from the Neutral zone.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 26 | +3.1% | +8.3% | ||
| Accumulation (current zone) | 197 | +1.5% | +2.3% | ||
| Neutral | 380 | +1.6% | +6.4% | ||
| Distribution | 73 | +1.6% | +11.5% | ||
| Selling | 6 | Too few readings yet | |||
Average AIP share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Arteris trades 28.9% below Gekko Fair Value of $30.19, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Arteris shares are worth, recalculated every trading day.
$30.19
Gekko Fair Value, Oct 10, 2026
28.9% Undervalued
At the end of Aug 2026 the price was 42.0% below the estimate.
No open-market insider purchases were filed for Arteris, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for AIP in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in AIP were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
0of the funds Gekko tracks hold AIP.
Arteris reports on Nov 3, 2026, after the close (22 days away), and beat the EPS estimate in 6 of its last 8 reports.
Nov 3, 2026
Expected after the close, 22 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | −$0.24 est −$0.16 | $24.13M est $23.48M | −3.7% |
| May 12, 2026 | −$0.03 est −$0.08 | $22.94M est $21.03M | +7.3% |
| Feb 12, 2026 | −$0.05 est −$0.08 | $20.14M est $18.55M | −3.2% |
| Nov 4, 2025 | −$0.09 est −$0.11 | $17.41M est $18.55M | +18.6% |
| Aug 5, 2025 | −$0.11 est −$0.11 | $16.50M est $16.35M | +4.7% |
| May 13, 2025 | −$0.09 est −$0.11 | $16.53M est $15.93M | −4.6% |
| Feb 18, 2025 | −$0.10 est −$0.11 | $15.49M est $15.34M | +2.4% |
| Nov 5, 2024 | −$0.08 est −$0.12 | $14.71M est $15.18M | +25.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Arteris is $39.43, +83.7% from the last close, from 7 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 7 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 21 | Craig-Hallum | $30 | +39.8% |
| Sep 21 | Craig-Hallum | $30 | +39.8% |
| Sep 3 | Northland Securities | $38 | +77.1% |
| Aug 7 | TD Cowen | $40 | +86.4% |
| Aug 7 | Jefferies | $50 | +133.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Arteris averaged +7.3% across the last 4 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.8% | 2 of 4 |
| Next 10 trading days | −2.4% | 1 of 4 |
| Next 15 trading days | −2.1% | 1 of 4 |
| Next 20 trading days | +7.3% | 3 of 4 |
| Next 30 trading days | −2.8% | 2 of 4 |
For scale, AIP’s typical 20-trading-day move in either direction is about 13.3%.
Arteris’s market cap is $990.6M and revenue of $84.62M over the last twelve months.
Coverage of Arteris this week reads neutral: 3 positive, 8 neutral and 0 negative headlines.
Arteris’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| NVDANVIDIA | Neutral | 14.8% below |
| AVGOBroadcom | Neutral | 1.3% below |
| MUMicron Technology | Accumulation | 27.3% below |
| AMDAdvanced Micro Devices | Neutral | 13.2% above |
| INTCIntel | Accumulation | 1.5% above |
| TXNTexas Instruments | Neutral | 8.2% above |
A peer links to its own page where one exists.
Arteris’s market cap is $990.6M at the Oct 12, 2026 close of $21.46, with 49.15M shares outstanding.
The consensus analyst 12-month price target for Arteris is $39.43, +83.7% from the last close. Of the 7 firms that rated the stock in the last 90 days, 7 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Arteris is undervalued: the Oct 12, 2026 close of $21.46 is 28.9% below Gekko Fair Value of $30.19. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Arteris is expected to report on Nov 3, 2026, after the market closes (22 days away). Analysts expect earnings of −$0.04 per share on revenue of $24.50M. Arteris beat the earnings estimate in 6 of its last 8 reports, moving 8.8% on average across the report.
Arteris’s 52-week high is $50.26 and its 52-week low is $12.06; it closed at $21.46 on Oct 12, 2026, +63.7% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and seasonality) and 2 as headwinds (trend and earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.